Zephyr AI
NEWS
Applications of the technology range from data collection to drug design to raising the alarm on product safety, but its adoption is also creating some anxiety.
Since the 2022 launch of ChatGPT, biopharma has poured money into this new form of artificial intelligence, but companies remain cautious with unproven technology.
Read the latest overview of people coming and going from executive positions at biopharma companies that BioSpace covers.
IN THE PRESS